The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1
Abstract
About 90 percent of human pancreatic carcinomas show allelic loss at chromosome 18q. To identify candidate tumor suppressor genes on 18q, a panel of pancreatic carcinomas were analyzed for convergent sites of homozygous deletion. Twenty-five of 84 tumors had homozygous deletions at 18q21.1, a site that excludes DCC (a candidate suppressor gene for colorectal cancer) and includes DPC4 , a gene similar in sequence to a Drosophila melanogaster gene ( Mad ) implicated in a transforming growth factor-β (TGF-β)-like signaling pathway. Potentially inactivating mutations in DPC4 were identified in six of 27 pancreatic carcinomas that did not have homozygous deletions at 18q21.1. These results identify DPC4 as a candidate tumor suppressor gene whose inactivation may play a role in pancreatic and possibly other human cancers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“SMAD4 is a tumor suppressor gene, and reported results about the prognostic value of SMAD4 have been inconsistent39,60–62.”
From Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma (2024) · cites this paper as [60]
In the citing paper
“SMAD4 is a tumor suppressor gene, and reported results about the prognostic value of SMAD4 have been inconsistent39,60–62.”
From Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma (2024) · cites this paper as [60]
Citations
Cites
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S. D., Wang, J., Myeroff, L. L., Parsons, R. E., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,267
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
Almoguera, C., Shibata, D. K., Forrester, K., Wj, M., Arnheim, N., & Perucho, M. (1988) · Cell · doi:10.1016/0092-8674(88)90571-5 · Cited by 2,122
pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
Hannon, G. J., & Beach, D. (1994) · Nature · doi:10.1038/371257a0 · Cited by 1,950
Weinberg, R. A. (1991) · Science · doi:10.1126/science.1659741 · Cited by 1,765
Identification of a Chromosome 18q Gene that Is Altered in Colorectal Cancers
Fearon, E. R., Cho, K. R., Nigro, J. M., Kern, S. E., Simons, J. W., Ruppert, J. M., Hamilton, S. R., Preisinger, A. C., Thomas, G., Kinzler, K. W., et al. (1990) · Science · doi:10.1126/science.2294591 · Cited by 1,760
Self-citationThe Molecular Genetics of Cancer
Bishop, J. M. (1987) · Science · doi:10.1126/science.3541204 · Cited by 1,674
Hereditary cancer, oncogenes, and antioncogenes.
Knudson, A. G. (1985) · PubMed · Cited by 1,218
Liu, Y., & Whittier, R. F. (1995) · Genomics · doi:10.1016/0888-7543(95)80010-j · Cited by 1,141
Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M. E. M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., & Kern, S. E. (1994) · Nature Genetics · doi:10.1038/ng0994-27 · Cited by 1,132
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- HAHN A. S., IN PRESS CANCER RES .
- LEACH S. F., COMMUNICATION .
Cited by
Sorted by citations
Items 701–800 of 1,002
Giehl, K., Seidel, B., Gierschik, P., Adler, G., & Menke, A. (2000) · Oncogene · doi:10.1038/sj.onc.1203806 · Cited by 76
Yamazaki, K., Masugi, Y., & Sakamoto, M. (2011) · Digestive Diseases · doi:10.1159/000327560 · Cited by 75
Metastasis in Pancreatic Ductal Adenocarcinoma: Current Standing and Methodologies
Pereira, M. A., & Chio, I. I. C. (2019) · Genes · doi:10.3390/genes11010006 · Cited by 75
Pancreatic Cytopathology: A Practical Approach and Review
Bellizzi, A. M., & Stelow, E. B. (2009) · Archives of Pathology & Laboratory Medicine · doi:10.5858/133.3.388 · Cited by 75
SMAD4 exerts a tumor-promoting role in hepatocellular carcinoma
Hernanda, P. Y., Chen, K., Das, A. M., Sideras, K., Wang, W., Li, J., Cao, W., Bots, S. J., Kodach, L. L., de Man, R. A., et al. (2014) · Oncogene · doi:10.1038/onc.2014.425 · Cited by 75
Hoang, M. P., Murakata, L. A., Katabi, N., Henson, D. E., & Albores‐Saavedra, J. (2002) · Modern Pathology · doi:10.1097/01.mp.0000036450.61830.8e · Cited by 75
Johnson, J. L., & de Mejı́a, E. G. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300307 · Cited by 75
Kikuchi, R., Tsuda, H., Kanai, Y., Kasamatsu, T., Sengoku, K., Hirohashi, S., Inazawa, J., & Imoto, I. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4567 · Cited by 68
Leslie, A., Pratt, N. R., Gillespie, K., Sales, M., Kernohan, N. M., Smith, G. C., Wolf, C. R., Carey, F. A., & Steele, R. J. (2003) · PubMed · Cited by 75
Growth Factors and Cytokines in Pancreatic Carcinogenesis
Friess, H., Guo, X., Nan, B., Kleeff, J. H., & Büchler, M. W. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09515.x · Cited by 75
Hammoud, Z. T., Kaleem, Z., Cooper, J. D., Sundaresan, R. S., Patterson, G. A., & Goodfellow, P. J. (1996) · PubMed · Cited by 75
Molecular profiling and risk stratification of adenocarcinoma of the colon
Mutch, M. G. (2007) · Journal of Surgical Oncology · doi:10.1002/jso.20915 · Cited by 73
RBBP9: A tumor-associated serine hydrolase activity required for pancreatic neoplasia
Shields, D. J., Niessen, S., Murphy, E. A., Mielgo, A., Desgrosellier, J. S., Lau, S. K. M., Barnes, L. A., Lesperance, J., Bouvet, M., Tarin, D., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911646107 · Cited by 75
Shimizu, A., Kato, M., Nakao, A., Imamura, T., ten Dijke, P., Heldin, C., Kawabata, M., Shimada, S., & Miyazono, K. (1998) · Genes to Cells · doi:10.1046/j.1365-2443.1998.00174.x · Cited by 73
Genome-Wide Characterization of Pancreatic Adenocarcinoma Patients Using Next Generation Sequencing
Liang, W. S., Craig, D. W., Carpten, J. D., Borad, M. J., Demeure, M. J., Weiss, G. J., Izatt, T., Sinari, S. A., Christoforides, A., Aldrich, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043192 · Cited by 73
Bachet, J., Maréchal, R., Demetter, P., Bonnetain, F., Couvelard, A., Svrcek, M., Bardier–Dupas, A., Hammel, P. R., Sauvanet, A., Louvet, C., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr617 · Cited by 73
The role of TGF-β and its crosstalk with RAC1/RAC1b signaling in breast and pancreas carcinoma
Melzer, C., Hass, R., von der Ohe, J., Lehnert, H., & Ungefroren, H. (2017) · Cell Communication and Signaling · doi:10.1186/s12964-017-0175-0 · Cited by 72
Functional Expression of HGF and Its Receptor in Human Colorectal Cancer
Otte, J., Schmitz, F., Kiehne, K., Stechele, H. U., Banasiewicz, T., Krokowicz, P., Nakamura, T., Fölsch, U. R., & Herzig, K. (2000) · Digestion · doi:10.1159/000007764 · Cited by 73
Amplification of SKI Is a Prognostic Marker in Early Colorectal Cancer
Buess, M., Terracciano, L., Reuter, J., Ballabeni, P., Boulay, J., Laffer, U. T., Metzger, U. F., Herrmann, R., & Rochlitz, C. F. (2004) · Neoplasia · doi:10.1593/neo.03442 · Cited by 73
Human lymphocyte telomerase is genetically regulated
Kosciolek, B. A., & Rowley, P. T. (1998) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199802)21:2 · Cited by 42
Prognostic Value of SMAD4 in Pancreatic Cancer: A Meta-Analysis
Shugang, X., Hongfa, Y., Jianpeng, L., Xu, Z., Jingqi, F., Xiangxiang, L., & Wei, L. (2016) · Translational Oncology · doi:10.1016/j.tranon.2015.11.007 · Cited by 72
Heterogeneity and Targeting of Pancreatic Cancer Stem Cells
Penchev, V. R., Rasheed, Z. A., Maitra, A., & Matsui, W. H. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3112 · Cited by 72
Silver, A., Moody, J., Dunford, R., Clark, D., Ganz, S., Bulman, R. A., Bouffler, S. D., Finnon, P., Meijne, E. I. M., Huiskamp, R., et al. (1999) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199902)24:2 · Cited by 72
Molecular lesions in colorectal cancer: impact on prognosis?
Klump, B., Nehls, O., Okech, T., Hsieh, C. ‐., Gaco, V., Gittinger, F. S., Sarbia, M., Borchard, F., Greschniok, A., Gruenagel, H. H., et al. (2003) · International Journal of Colorectal Disease · doi:10.1007/s00384-003-0499-7 · Cited by 72
Carcinoid Tumors of the Extrahepatic Bile Ducts
Maitra, A., Krueger, J. E., Tascilar, M., Offerhaus, G. J. A., Angeles[ndash]Angeles, A., Klimstra, D. S., Hruban, R. H., & Albores[ndash]Saavedra, J. (2000) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200011000-00005 · Cited by 72
Self-citationCounting alleles reveals a connection between chromosome 18q loss and vascular invasion
Zhou, W., Galizia, G., Goodman, S. N., Romans, K. E., Kinzler, K. W., Vogelstein, B., Choti, M. A., & Montgomery, E. A. (2001) · Nature Biotechnology · doi:10.1038/83572 · Cited by 72
Expression and functional significance of CDC25B in human pancreatic ductal adenocarcinoma
Guo, J., Kleeff, J. H., Li, J., Ding, J., Hammer, J., Zhao, Y., Giese, T., Korc, M., Büchler, M. W., & Frieß, H. (2004) · Oncogene · doi:10.1038/sj.onc.1206926 · Cited by 72
McCarthy, A. J., & Chetty, R. (2018) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2018-205095 · Cited by 71
SMAD4 Expression Predicts Local Spread and Treatment Failure in Resected Pancreatic Cancer
Yamada, S., Fujii, T., Shimoyama, Y., Kanda, M., Nakayama, G., Sugimoto, H., Koike, M., Nomoto, S., Fujiwara, M., Nakao, A., et al. (2015) · Pancreas · doi:10.1097/mpa.0000000000000315 · Cited by 71
Fokas, E., O’Neill, E., Gordon-Weeks, A. N., Mukherjee, S., McKenna, W. G., & Muschel, R. J. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.12.001 · Cited by 75
Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward
Khan, M. A., Azim, S., Zubair, H., Bhardwaj, A., Patel, G. K., Khushman, M. M., Singh, S., & Singh, A. P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040779 · Cited by 73
The pancreatic cancer microenvironment: A true double agent
Melstrom, L. G., Salazar, M. D., & Diamond, D. J. (2017) · Journal of Surgical Oncology · doi:10.1002/jso.24643 · Cited by 74
Yamazaki, K., Takamura, M., Masugi, Y., Mori, T., Du, W., Hibi, T., Hiraoka, N., Ohta, T., Ohki, M., Hirohashi, S., et al. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.5 · Cited by 71
Yu, H., Shen, Y., Hong, J., XIA, Q., ZHOU, F., & Liu, X. (2015) · Neoplasma · doi:10.4149/neo_2015_002 · Cited by 71
Transforming growth factor-beta-induced growth inhibition in a Smad4 mutant colon adenoma cell line.
Fink, S. P., Swinler, S. E., Lutterbaugh, J., Massagué, J., Thiagalingam, S., Kinzler, K. W., Vogelstein, B., Willson, J. K. V., & Markowitz, S. D. (2001) · PubMed · Cited by 71
Meersseman, G., Verschueren, K., Nelles, L., Blumenstock, C., Kraft, H. J., Wuytens, G., Remacle, J., Kozak, C. A., Tylżanowski, P., Niehrs, C., et al. (1997) · Mechanisms of Development · doi:10.1016/s0925-4773(96)00629-6 · Cited by 71
Aurich, J., Dastugue, N., Duchayne, É., Schlaifer, D., Huguet, F., & Caballín, M. R. (1997) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199710)20:2 · Cited by 29
Zhang, L., Niu, H., Ma, J., Yuan, B., Chen, Y., Zhuang, Y., Chen, G., Zeng, Z., & Xiang, Z. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1044-9 · Cited by 70
Scolaro, T., Manco, M., Pecqueux, M., Amorim, R., Trotta, R., Acker, H. H. V., Haele, M. V., Shirgaonkar, N., Naulaerts, S., Daniluk, J., et al. (2024) · Nature Cancer · doi:10.1038/s43018-024-00771-8 · Cited by 73
Modulation of TGF-beta signaling during progression of chronic liver diseases
Matsuzaki, K. (2009) · Frontiers in bioscience · doi:10.2741/3423 · Cited by 70
Epithelial-Mesenchymal Transition in Pancreatic Carcinoma
Maier, H. J., Wirth, T., & Beug, H. (2010) · Cancers · doi:10.3390/cancers2042058 · Cited by 71
Detection of K- ras mutations in the plasma DNA of pancreatic cancer patients
Nakao, A., Hibi, K., Kaneko, T., Takeda, S., Inoue, S., Okochi, O., Uemura, T., & Nagasaka, T. (2004) · Journal of Gastroenterology · doi:10.1007/s00535-003-1245-1 · Cited by 70
Hedgehog Signaling in the Normal and Diseased Pancreas
Kayed, H., Kleeff, J. H., Osman, T., Keleg, S., Büchler, M. W., & Friess, H. (2006) · Pancreas · doi:10.1097/01.mpa.0000202937.55460.0c · Cited by 70
McCarthy, D. M., Hruban, R. H., Argani, P., Howe, J. R., Conlon, K. C., Brennan, M. F., ZAHURAK, M. L., Wilentz, R. E., Cameron, J. L., Yeo, C. J., et al. (2003) · Modern Pathology · doi:10.1097/01.mp.0000057246.03448.26 · Cited by 70
Self-citationActivins and activin antagonists in hepatocellular carcinoma
Deli, A. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.1699 · Cited by 70
Two sides of the story? Smad4 loss in pancreatic cancer versus head-and-neck cancer
Malkoski, S., & Wang, X.-J. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.01.054 · Cited by 68
Chow, J. Y. C., Dong, H., Quach, K. T., Nguyen, P. N. V., Chen, K., & Carethers, J. M. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00411.2007 · Cited by 70
Molecular Diagnosis of Early Pancreatic Ductal Adenocarcinoma in High-Risk Patients
Wong, T., Howes, N., Threadgold, J., Smart, H. L., Lombard, M. G., Gilmore, I. T., Sutton, R., Greenhalf, W., Ellis, I., & Neoptolemos, J. P. (2001) · Pancreatology · doi:10.1159/000055852 · Cited by 70
Crystal structure of a transcriptionally active Smad4 fragment
Qin, B. Y., Lam, S. S., & Lin, K. F. (1999) · Structure · doi:10.1016/s0969-2126(00)88340-9 · Cited by 70
Progress in cancer genetics: Lessons from pancreatic cancer
Goggins, M., Kern, S. E., Offerhaus, J. G. A., & Hruban, R. H. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_4.s4 · Cited by 75
Self-citationNiedergethmann, M., Alves, F., Neff, J., Heidrich, B., Aramin, N., Li, L., Pilarsky, C. P., Grützmann, R., Allgayer, H., Post, S., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604031 · Cited by 68
Kayed, H., Kleeff, J. H., Kolb, A., Ketterer, K., Keleg, S., Felix, K., Giese, T., Penzel, R., Zentgraf, H., Büchler, M. W., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21257 · Cited by 69
Baek, H. J., Lim, S., Kitisin, K., Jogunoori, W. S., Tang, Y., Marshall, M. B., Mishra, B., Kim, T. H., Cho, K. H., Kim, S. S., et al. (2008) · Hepatology · doi:10.1002/hep.22460 · Cited by 69
The molecular mechanism of ovarian granulosa cell tumors
Li, J., Bao, R., Peng, S., & Zhang, C. (2018) · Journal of Ovarian Research · doi:10.1186/s13048-018-0384-1 · Cited by 69
Wilkins-Port, C. E., & Higgins, P. J. (2007) · Cells Tissues Organs · doi:10.1159/000101312 · Cited by 69
Genetic alterations and biological pathways in human bladder cancer pathogenesis
Reznikoff, C. A., Sarkar, S., Jülicher, K., Burger, M. S., Puthenveettil, J. A., Jarrard, D. F., & Newton, M. A. (2000) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/s1078-1439(00)00079-x · Cited by 69
Suppression of Human Pancreatic Carcinoma Cell Growth and Invasion by Epigallocatechin-3-Gallate
Takada, M., Nakamura, Y., Koizumi, T., Toyama, H., Kamigaki, T., Suzuki, Y., Takeyama, Y., & Kuroda, Y. (2002) · Pancreas · doi:10.1097/00006676-200207000-00012 · Cited by 68
Carvalho, A. L., Chuang, A., Jiang, W.-W., Lee, J., Begum, S., Poeta, M. L., Zhao, M., Jerónimo, C., Henrique, R., Nayak, C. S., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1073 · Cited by 68
Biswas, S., Criswell, T. L., Wang, S. E., & Arteaga, C. L. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0952 · Cited by 68
Nuclear Targeting of Transforming Growth Factor-β-activated Smad Complexes
Chen, H. B., Rud, J., Lin, K. F., & Xu, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500362200 · Cited by 68
The DAF-3 Smad binds DNA and represses gene expression in the Caenorhabditis elegans pharynx
Thatcher, J. D., Haun, C., & Okkema, P. G. (1999) · Development · doi:10.1242/dev.126.1.97 · Cited by 68
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
Dunne, R. F., & Hezel, A. F. (2015) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2015.04.003 · Cited by 68
Determinants of nutrient limitation in cancer
Sullivan, M. R., & Heiden, M. G. V. (2019) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2019.1611733 · Cited by 70
SMAD4 Loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells
Chen, Y.-W., Hsiao, P., Weng, C., Kuo, K., Kuo, T., Wu, D., Hung, W., & Cheng, K. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-181 · Cited by 72
Liu, X., Lee, J., Cooley, M. A., Bhogte, E., Hartley, S., & Glick, A. B. (2003) · PubMed · Cited by 67
Güngör, C., Hofmann, B. T., Wolters‐Eisfeld, G., & Bockhorn, M. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12401 · Cited by 67
Inactivation of Smad4 in gastric carcinomas.
Powell, S. M., Harper, J. C., Hamilton, S. R., Robinson, C., & Cummings, O. W. (1997) · PubMed · Cited by 67
Angelis, P. M. D., Stokke, T., Beigi, M., Mjåland, O., & Clausen, O. P. F. (2001) · International Journal of Colorectal Disease · doi:10.1007/s003840000275 · Cited by 67
Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q
Yin, Z., Babaian, R. J., Troncoso, P., Strom, S. S., Spitz, M. R., Caudell, J. J., Stein, J. D., & Kagan, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204310 · Cited by 67
Role of Genomic Markers in Colorectal Cancer Treatment
Allen, W. L., & Johnston, P. G. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.19.752 · Cited by 66
Frequent loss of expression without sequence mutations of the DCC gene in primary gastric cancer
Sato, K., Tamura, G., Tsuchiya, T., Endoh, Y., Usuba, O., Kimura, W., & Motoyama, T. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1888 · Cited by 67
Bone morphogenetic protein signaling transcription factor (SMAD) function in granulosa cells
Pangas, S. A. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.06.021 · Cited by 66
Jazag, A., Ijichi, H., Kanai, F., Imamura, T., Guleng, B., Ohta, M., Imamura, J., Tanaka, Y., Tateishi, K., Ikenoue, T., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1208102 · Cited by 68
Roelen, B. A. J., Cohen, O. S., Raychowdhury, M. K., Chadee, D. N., Zhang, Y. E., Kyriakis, J. M., Alessandrini, A., & Lin, H. Y.-F. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00053.2003 · Cited by 66
Kanzler, S., Meyer, E., Lohse, A. W., Schirmacher, P., Henninger, J., Galle, P. R., & Blessing, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204544 · Cited by 66
Wagner, M., Lopez, M. E., Cahn, M., & Korc, M. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70594-3 · Cited by 66
Glick, A. B., Popescu, N. C., Alexander, V., Ueno, H., Böttinger, E. P., & Yuspa, S. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14949 · Cited by 65
Peng, B., Fleming, J. B., Breslin, T. M., Grau, A. M., Fojioka, S., Abbruzzese, J. L., Evans, D. B., Ayers, D., Wathen, K., Wu, T., et al. (2002) · PubMed · Cited by 66
Absence or low number of telomere repeats at junctions of dicentric chromosomes
Wan, T. S. K., Martens, U. M., Poon, S. S. S., Tsao, S., Ha, S., & Lansdorp, P. M. (1999) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199901)24:1 · Cited by 45
Pancreatic Cancer Metastasis: Are we being Pre-EMTed?
Das, S., & Batra, S. K. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666141211115234 · Cited by 65
Promoter‐wide analysis of Smad4 binding sites in human epithelial cells
Koinuma, D., Tsutsumi, S., Kamimura, N., Imamura, T., Aburatani, H., & Miyazono, K. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01299.x · Cited by 70
Tascilar, M., Offerhaus, G. J. A., Altink, R., Argani, P., Sohn, T. A., Yeo, C. J., Cameron, J. L., Goggins, M., Hruban, R. H., & Wilentz, R. E. (2001) · American Journal of Clinical Pathology · doi:10.1309/wf03-nfce-7brh-7c26 · Cited by 65
Self-citationAberrant signaling pathways in pancreatic cancer: A two compartment view
McCleary‐Wheeler, A. L., McWilliams, R. R., & Fernández-Zapico, M. E. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20827 · Cited by 69
Signal Transduction of the TGF- Superfamily by Smad Proteins
Kawabata, M., & Miyazono, K. (1999) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022273 · Cited by 64
Genome-wide analyses on loss of heterozygosity in hepatocellular carcinoma in Southern China
Li, S., Wang, H., Li, J.-Q., Zhang, C., Feng, Q.-S., Huang, P., Yu, X.-J., Huang, L.-X., Liang, Q.-W., & Zeng, Y.-X. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00047-2 · Cited by 65
Prognostic significance of the expression of Smad4 and Smad7 in human gastric carcinomas
Kim, Y., Lee, H. S., Lee, H., Hur, K., Kim, W. H., Bang, Y. J., Kim, S., Lee, K., Choe, K. J., & Yang, H.-K. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh131 · Cited by 65
Bone Morphogenetic Protein (BMP)-2 Induces Apoptosis in Human Myeloma Cells
Kawamura, C., Kizaki, M., & Ikeda, Y. (2002) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190290012182 · Cited by 65
Iacobuzio–Donahue, C. A., van der Heijden, M. S., Baumgartner, M. R., Troup, W. J., Romm, J., Doheny, K. F., Pugh, E., Yeo, C. J., Goggins, M., Hruban, R. H., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2756 · Cited by 65
Self-citationDCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination
Tarafa, G., Villanueva, A., Farré, L., Rodriguez, J. C., Musulén, E., Reyes, G., Seminago, R., Olmedo, E., Paules, A., Peinado, M. A., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203353 · Cited by 65
Carcinogenesis of Pancreatic Adenocarcinoma: Precursor Lesions
Gnoni, A., Licchetta, A., Scarpa, A., Azzariti, A., Brunetti, A. E., Simone, G., Nardulli, P., Santini, D., Aieta, M., Delcuratolo, S., et al. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141019731 · Cited by 64
Onwuegbusi, B. A., Aitchison, A., Chin, S.-F., Kranjac, T., Mills, I. G., Huang, Y., Lao‐Sirieix, P., Caldas, C., & Fitzgerald, R. C. (2005) · Gut · doi:10.1136/gut.2005.076430 · Cited by 64
Tsui, I. F. L., Poh, C. F.-Y., Garnis, C., Rosin, M. P., Zhang, L., & Lam, W. L. (2009) · International Journal of Cancer · doi:10.1002/ijc.24611 · Cited by 64
Semba, S., Moriya, T., Kimura, W., & Yamakawa, M. (2003) · Pancreas · doi:10.1097/00006676-200304000-00008 · Cited by 64
Dellas, A., Torhorst, J. K. H., Jiang, F., Proffitt, J. H., Schultheiss, E., Holzgreve, W., Sauter, G., Mihatsch, M. J., & Moch, H. (1999) · PubMed · doi:10.5451/unibas-ep6479 · Cited by 64
Liang, J. J., Zhu, S., Bruggeman, R., Zaino, R. J., Evans, D. B., Fleming, J. B., Gomez, H. F., Zander, D. S., & Wang, H. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0405 · Cited by 64
Induction and expression of βig-h3 in pancreatic cancer cells
Schneider, D. T., Kleeff, J. H., Berberat, P. O., Zhu, Z., Korc, M., Friess, H., & Büchler, M. W. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00052-2 · Cited by 64
Medical Applications of Transforming Growth Factor-
Flanders, K. C., & Burmester, J. K. (2003) · Clinical Medicine & Research · doi:10.3121/cmr.1.1.13 · Cited by 64
MOLECULAR GENETIC ALTERATIONS IN DUCTAL PANCREATIC ADENOCARCINOMAS
Kern, S. E. (2000) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70251-0 · Cited by 64
Self-citationDPC4/SMAD4 gene alterations in human cancer, and their functional implications
Schutte, M. E. M. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_4.s56 · Cited by 64
Self-citationLoss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan
Sheu, J., Lin, Y.-W., Chou, H.-C., Huang, G.-T., Lee, M., Lin, Y.-H., Huang, S.-Y., Chen, C., Wang, J.-T., Lee, P.-H., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690380 · Cited by 64
Metadata
- Authors
- Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., & Kern, S. E.
- Affiliations
- Johns Hopkins University (US)
- S. A. Hahn, M. Schutte, A. T. M. S. Hoque, C. A. Moskaluk, E. Rozenblum, C. L. Weinstein, A. Fischer, R. H. Hruban, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
- L. T. da Costa, Graduate Program in Human Genetics and Molecular Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
- Corresponding author
- Kern, Scott E.
- ORCID
- Venue
- Science
- Published
- 1996-01-19
- Volume
- 271
- Issue
- 5247
- Pages
- 350-353
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2100522747
- Cited by
- 2,337
- References
- 25
- Citations by year
- 2026: 20 · 2025: 21 · 2024: 29 · 2023: 26 · 2022: 31 · 2021: 41 · 2020: 33 · 2019: 44 · 2018: 41 · 2017: 46 · 2016: 55 · 2015: 59 · 2014: 71 · 2013: 64 · 2012: 67
- FWCI
- 70.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (P50CA062924, CA 62924)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- SMAD4, tumor suppressor, pancreatic cancer, homozygous deletion, loss of heterozygosity, TGF-beta signaling, loss-of-function mutations, candidate gene identification
- MeSH terms
- Alleles, Amino Acid Sequence, Animals, Base Sequence, Cell Division, Chromosome Mapping, Chromosomes, Human, Pair 18, DNA-Binding Proteins, Genetic Markers, Humans, Molecular Sequence Data, Mutation, Neoplasm Transplantation, Pancreatic Neoplasms, Proteins, Transplantation, Heterologous, Tumor Cells, Cultured, Signal Transduction, Trans-Activators, Gene Expression, Genes, Tumor Suppressor, Transforming Growth Factor beta, Gene Deletion, Mice, Smad4 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review